It is to become used concomitantly with ciclosporin for microemulsion- and corticosteroid-based immunosuppression, in individuals with panel reactive antibodies under 80%, or in a triple upkeep immunosuppressive regimen made up of ciclosporin for microemulsion, corticosteroids and possibly azathioprine or mycophenolate mofetil.Prior to employing We